Preterm Birth in Caucasians Is Associated with Coagulation and Inflammation Pathway Gene Variants by Velez, Digna R. et al.
Preterm Birth in Caucasians Is Associated with
Coagulation and Inflammation Pathway Gene Variants
Digna R. Velez
1, Stephen J. Fortunato
2,3*, Poul Thorsen
4, Salvatore J. Lombardi
2, Scott M. Williams
1*,
Ramkumar Menon
2,4
1Center for Human Genetics Research, Vanderbilt University, Nashville, Tennessee, United States of America, 2The Perinatal Research Center, Nashville, Tennessee, United
States of America, 3Department of Obstetrics and Gynecology and Reproductive Science, Yale University, New Haven, Connecticut, United States of America, 4Northern
Atlantic Epidemiologic Alliance, University of Aarhus, Aarhus, Denmark
Abstract
Spontaneous preterm birth (,37 weeks gestation—PTB) occurs in ,12% of pregnancies in the United States, and is the
largest contributor to neonatal morbidity and mortality. PTB is a complex disease, potentially induced by several etiologic
factors from multiple pathophysiologic pathways. To dissect the genetic risk factors of PTB a large-scale high-throughput
candidate gene association study was performed examining 1536 SNP in 130 candidate genes from hypothesized PTB
pathways. Maternal and fetal DNA from 370 US Caucasian birth-events (172 cases and 198 controls) was examined. Single
locus, haplotype, and multi-locus association analyses were performed separately on maternal and fetal data. For maternal
data the strongest associations were found in genes in the complement-coagulation pathway related to decidual
hemorrhage in PTB. In this pathway 3 of 6 genes examined had SNPs significantly associated with PTB. These include factor
V (FV) that was previously associated with PTB, factor VII (FVII), and tissue plasminogen activator (tPA). The single strongest
effect was observed in tPA marker rs879293 with a significant allelic (p=2.30610
23) and genotypic association
(p=2.0610
26) with PTB. The odds ratio (OR) for this SNP was 2.80 [CI 1.77–4.44] for a recessive model. Given that 6 of 8
markers in tPA were statistically significant, sliding window haplotype analyses were performed and revealed an associating
4 marker haplotype in tPA (p=6.00610
23). The single strongest effect in fetal DNA was observed in the inflammatory
pathway at rs17121510 in the interleukin-10 receptor antagonist (IL-10RA) gene for allele (p=0.01) and genotype
(p=3.34610
24). The OR for the IL-10RA genotypic additive model was 1.92 [CI 1.15–3.19] (p=2.00610
23). Finally,
exploratory multi-locus analyses in the complement and coagulation pathway were performed and revealed a potentially
significant interaction between a marker in FV (rs2187952) and FVII (rs3211719) (p,0.001). These results support a role for
genes in both the coagulation and inflammation pathways, and potentially different maternal and fetal genetic risks for PTB.
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Introduction
Preterm birth (,37 weeks gestation—PTB) accounts for 12.0–
13.0% of pregnancies in the United States [1,2] and the rate in
Caucasians has been trending upward in the last decade [3,4].
PTB is associated with a 40-fold increase in neonatal morbidity
and mortality [5–7]. The majority of these PTB result from
spontaneous contractions (labor) of idiopathic causes [8]. It has
become well established that PTB has a genetic component [9–
14]. Family history of PTB [9,11–14], twin studies that estimated
heritability between 20 and 40%, [15,16], and association between
ethnicity/race and PTB [11,17] support this conclusion. Although
these data are not conclusive, they do suggest that genetic
variation influences PTB susceptibility.
Data from previously published studies in both in vivo and in vitro
human and animal models suggests that four primary pathogenic
pathways either independently or through interactions lead to
PTB [18]. The four proposed pathways are: 1) activation of
maternal or fetal hypothalamic-pituitary-adrenal (HPA) axis; 2)
decidual-chorioamniotic or systematic inflammation; 3) decidual
hemorrhage (abruption) and 4) pathological distention of the
uterus [18]. All pathways culminate in a common terminal
pathway that causes the release of uterotonins, such as
prostaglandins, leading to preterm labor and delivery [18].
Complex and poorly understood etiology underlying PTB and
the increasing trends of PTB rates in Caucasians, led us to perform
a large-scale PTB candidate gene association study on a US
Caucasian population. In this case (PTB)-control (term birth after
a normal pregnancy) study we examined 1536 single nucleotide
polymorphisms (SNPs) in 130 candidate genes from the four
hypothesized pathways. Given the complex exchange of genetic
information at the maternal-fetal unit during pregnancy, both
maternal and fetal DNA were analyzed. Single locus, haplotype,
and multi-locus tests of association were performed.
Methods
Study population
Subjects were recruited at the Centennial Medical Center,
Nashville, TN between September 2003 and December of 2006.
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Vanderbilt University, Nashville, TN approved this study. All
included pregnancies were singleton live births. Race was
identified by self-report and a questionnaire that traces ethnicity
back two generations from the parents. Individuals who had more
than one racial group in their ancestry were excluded from the
study. Mothers between the ages of 18 and 40 were recruited.
Gestational age was determined by last menstrual period and
corroborated by ultrasound dating. In our study, PTB (cases) were
defined as presence of regular uterine contractions (a minimum
frequency of 2 contractions/10 minutes) and cervical changes
followed by delivery at ,36
0/7 weeks gestation. The control group
consisted of women having normal labor and delivery at term
($37
0/7 weeks) with no medical of obstetrical complications
during pregnancy. A cut-off of ,36
0/7 weeks gestation was used in
order to correct for the lack of precision of measurements of last
menstrual dating and ultrasound dating. Subjects with multiple
gestations, preeclampsia, preterm premature rupture of the
membranes, placental previa, fetal anomalies, gestational diabetes,
poly- and oligohydramnios, and other complications such as
surgeries during pregnancies were excluded. DNA was collected
from maternal blood and fetal cord blood.
Demographic and clinical characteristics
Our study included 172 cases and 198 controls Caucasian birth-
events including both maternal (145 cases and 194 controls) and
fetal (140 cases and 179 controls) DNA from both mother-baby
pairs and individual maternal and fetal samples. Demographic and
clinical data were obtained from questionnaires and medical
records.
In our study, microbial invasion of the amniotic cavity (MIAC)
was defined either by presence of microbial 16s ribosomal DNA
(TaqMan Assay, CA) detected by polymerase chain reaction
(PCR) and/or clinical evidence [19,20]. Cases with clinical
evidence of MIAC were those individuals having three or more
of the following criteria: abdominal tenderness, temperature
.40uC, foul smelling vaginal discharge, an elevated C-reactive
protein (CRP.0.8 U/ml)) or histologic chorioamnionitis.
DNA sampling and genotyping
DNA was isolated from maternal and fetal blood samples using
the Autopure automated system (Gentra Systems (Minneapolis,
MN)). A total of 1536 tag single nucleotide polymorphisms (SNPs)
were screened in 130 PTB candidate genes (Supplemental Table
S1)(4 other genes were within 5000 kb of a candidate gene and
were analyzed as members of the established candidate). We chose
SNPs based on their ability to tag surrounding variants in the
CEPH and Yoruba population of the HapMap database (http://
www.hapmap.org), using a minor allele frequency (MAF) of 0.07
in CEPH and 0.20 in Yoruba and r
2$0.80, as our original study
consisted of African Americans and Caucasians. Final analysis
included 1432 markers after removing monomorphic markers and
those markers that were not genotyped successfully. We also
included functional SNPs and previously associated SNPs as
selection criteria. Genotyping was performed by Illumina’s
GoldenGate genotyping system (http://www.illumina.com/Gen-
eral/pdf/LinkageIV/GOLDENGATE_ASSAY_FINAL.pdf).
Bioinformatics tools
Marker positions (base pair - bp), marker function, and amino
acid changes were identified using the SNPper (http://snpper.
chip.org) database and using NCBI Build 35.1. Kyoto encyclope-
dia of genes and genomes (KEGG) (http://www.genome.ad.jp/
kegg/pathway.html) was used to examine gene ontology and to
group genes into potential biological pathways
Statistical analysis
Clinical and demographic characteristics between cases and
controls were compared, using Shapiro-Wilks tests of normality on
gravidity (number of previous pregnancies), gestational age (days),
gestational weight (grams - g), APGAR 1, and APGAR 5. All
measurements deviated significantly from normality; as a result
Mann-Whitney two-sample ranksum tests were used to compare
case and control groups [21]. Standard t-tests were used to test
whether maternal age differed between cases and controls. x
2 tests
were used to test for differences in the counts of smokers and non-
smokers between cases and controls. STATA 9.0 statistical
software [22] was used for all analyses.
Samples analyzed represent those cleaned for Mendelian
inconsistency on mother-baby pairs. Statistical tests for differences
in single locus allele and genotype frequencies, for deviations from
Hardy Weinberg Equilibrium (HWE) and for measurements of
inbreeding coefficients (f) were calculated using Powermarker
statistical software [23]. The inbreeding coefficient is a measure of
deviations from expected heterozygosity under random mating
and ranges from 21 to 1. Statistical significance for these analyses
was determined using Fishers Exact tests. Initially, allelic and
genotypic Fisher’s Exact tests were performed, and only those
associations with a p#10
23 in either test were followed-up with
additive, dominant, and recessive genotypic models, using logistic
regression. For the logistic regression additive models risk was
based on the presence of the minor allele with the homozygous
major genotype used as the referent group. Dominant and
recessive models were performed, modeling both the minor and
major allele as the risk alleles. These analyses were performed
using STATA 9.0 statistical software. Logistic regression analyses
adjusting for confounding variables, smoking and gravidity, were
then performed on the most significant associations (i.e., the best of
the additive, dominant, or recessive model for those markers with
p#10
23). Smoking was modeled with non-smokers as the referent
group and gravidity was modeled with zero previous pregnancies
as the referent. Explicit tests for gene-environment interactions
were not performed.
Pairwise linkage disequilibrium (LD) was characterized and
haplotype frequencies were calculated using Powermarker [23,24]
and HaploView [25] statistical software. Standard summary
statistics D’ and r
2 were calculated using HaploView [26].
Haplotype blocks were assigned using the D’ confidence interval
algorithm created by Gabriel et al (2002) [27]. Both Powermarker
and HaploView use an EM algorithm to determine haplotype
frequency distributions when phase is unknown. The Power-
marker haplotype trend analysis was performed for dichotomous
outcome with 2, 3 and 4 marker sliding windows, using 10,000
permutations in order to determine p - values. This analysis is a
regression approach to test haplotype-trait association. The test for
association then uses an F test for a specialized additive model.
The strongest associated sliding window was then analyzed for
haplotype specific effects. This included the calculation of Odds
Ratios (OR) for each haplotype, as well as determination of PTB
and term haplotype frequencies. The highest frequency haplotype
was used as the baseline haplotype frequency. Only haplotypes
with a frequency of 5% or more were considered for haplotype
analyses and only significant haplotypes are reported.
Genes were grouped into KEGG biological process pathways
and Z tests were used to determine if the total number of
significant single locus allele and genotype associations within
genes of a pathway deviated statistically from expected number of
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size. These analyses used only tag SNPs (r
2$0.6) in order to
correct for lack of independence between markers within a gene
due to LD.
Exploratory multi-locus analyses were performed, using Multi-
factor Dimensionality Reduction (MDR) that has been previously
described in Ritchie et al 2001 and is available as open source
software at www.epistasis.org [28].
Results are presented for the following analyses: 1) single locus
tests of association with p values#10
23 for either allele or
genotype tests of association; 2) haplotype tests for genes with at
least 1 marker with a p values#10
23, 3 or more markers within
the genes and with at least 1/3 of the markers statistically
significant at the p=0.05 level; 3) Z-tests within KEGG pathways
testing for deviations from expected number of significant tests
(either allele or genotype) given the number of tests performed.
Results
Baseline characteristics
Significant differences between cases and controls were
observed for gestational age (days) (p,0.001), birth weight (g)
(p,0.001), APGAR 1 (1 minute after birth) (p,0.001), APGAR 5
(5 minutes after birth)(p,0.001), gravidity (number of births)
(p=0.02), and smoking (p,0.001) (Table 1).
Single locus tests of associations
Table 2 presents the results for the single locus allele and
genotype associations and ORs for the best model at each marker.
Among all of the 1432 SNPs analyzed 122 were statistically
significant at the 0.05 level for either allelic or genotypic tests of
associations in maternal samples and 112 were significant in fetal
samples (Supplemental Table S2 and S3).
In maternal data the most significant results (p,0.001) were
observed in markers from corticotrophin releasing hormone
binding protein (CRHBP, OMIM # 122559), coagulation factor
V (FV, OMIM # 227400), interleukin 5 (IL-5, OMIM # 600554),
prostaglandin E receptor 3 (PTGER3, OMIM # 176806), and
tissue plasminogen activator (tPA/PLAT, OMIM # 173370)
(Tables 2 and 3). The single most significant association was seen
in tPA at rs879293 (allele p=2.30610
23; genotype
p=2.00610
26) with a case minor allele frequency (MAF)=0.35
and a control MAF=0.46. The best model for this marker was
GG vs. AG & AA (Table 2) with an OR=2.80 [CI 1.77–4.44] and
p,1.00610
26. Upon examining maternal genotypic associations,
rs879293 in tPA remains significant after a Bonferroni correction.
Six of the eight SNPs genotyped in tPA had a statistically
significant single locus allelic and/or genotypic association, but the
other SNPs failed to hold up to a Bonferroni correction.
The most significant results in fetal samples were seen in
markers from cystathionine-beta-synthase (CBS, OMIM #
236200), interleukin 10 receptor alpha (IL-10RA, OMIM #
146933), klotho isoform b (KL, OMIM # 604824), and triggering
receptor expressed on myeloid cells 1 (TREM1, OMIM #
605085) (Table 2 and 4). The most significant association was seen
in IL-10RA rs17121510 (allele p=0.01; genotype p=3.34610
24)
with the case MAF=0.15 and a control MAF=0.09. The most
significant model for rs17121510 was AA vs. AG & GG with a
protective OR=0.43 [CI 0.25–0.74] (p=2.00610
23) (Table 2). In
the fetal data the most significant ORs were for IL-10RA
rs17121510, KL rs522796 (OR=1.52 [CI 1.17–1.96]), and
TREM1 rs6910730 (OR=2.30 [CI 1.34–3.95]) all had equally
significant results with p=2.00610
23; both KL rs522796 and
TREM1 rs6910730 were additive models. However, none of these
were significant after Bonferroni correction.
Model p-values for associated markers were adjusted for
demographic variables that had baseline differences between cases
and controls (Table 5) such as smoking and gravidity. In maternal
data all markers remained statistically significant after adjustments,
with the exception of FV rs9332624, IL-5 rs739718, and PTGER3
rs977214. In fetal data all significance was lost with the exception
of KL marker rs522796.
Given that the presence of microbial invasion of the amniotic
cavity (MIAC) in cases may influence associations, we examined
markers for allele and genotype difference between cases with and
without MIAC (Table 6). There were no differences for any of the
markers we examined in maternal or fetal data at either the allele
or genotype level except fetal marker TREM1 rs6910730 that
differed between MIAC and no MIAC at both the allele (p=0.02)
and genotype level (p=0.05).
Among the markers with p#10
23, seven deviated from HWE
for either cases or controls (Table 2). Five were from maternal
data, one in cases at tPA rs879293 (p=0.01) and PTGER3
rs977214 (p=0.02) and one in control at IL-5 rs739718 (p=0.02),
tPA rs879293 (p=0.01), and at PTGER3 rs594454 (p=0.05).
One was from fetal cases at IL-10RA marker rs17121510
(p=0.02) and one was in fetal controls at CBS marker
rs12329764 (p=0.01). It is of note that for most situations where
p,0.05 for HWE tests there is evidence that the inbreeding
coefficients were in opposite directions in cases and controls.
Specifically, for rs879293 in maternal samples the inbreeding
coefficient, f, was 0.2313 in cases but in controls it was 20.1808,
and for rs977214 f was 0.1463 in cases but 20.1420 in controls.
Similarly for fetal samples, f differed in sign between cases and
Table 1. Clinical and demographic information
Variable Cases Mean (SD) or Median[IQR] Controls Mean (SD) or Median[IQR] P-Value
1
Gravidity (number of births) 2 [1–9] 2 [1–8] 0.02
Gestational Age (days) 239 [166–255] 274 [257–296] ,0.001
Gestational Weight(g) 2150 [370–3790] 3446 [2100–4661] ,0.001
APGAR 1 8 [1–9] 8 [4–9] ,0.001
APGAR 5 9 [1–9] 9 [7–10] ,0.001
Maternal Age(yrs) 27.33 (6.30) 28.39 (5.80) 0.10
Smoking (%) 31.77% 14.74% ,0.001
Means are reported with standard deviations reported in parentheses and medians are reported with interquartile ranges in brackets
1P-values compare cases (PTB) to controls (term)
doi:10.1371/journal.pone.0003283.t001
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exception was rs739718 where the inbreeding coefficients were
positive in both maternal cases and controls (0.0848 and 0.1133,
respectively). Simulation studies published by Wittke-Thompson et
al.[29] suggested that if inbreeding coefficients are of opposite
signs in cases and controls this can be indicative of an association
and not due to a genotyping error. In our data this suggests that
the deviations are not likely due to genotyping error, as cases and
controls were mixed on the plates for genotyping.
Details regarding the associated markers are on Table 3 for
maternal and Table 4 for fetal data. Among these markers one was
a coding exon only in fetal data (KL rs9527025, nonsynonymous
amino acid change 370 S/C). The remaining markers were in
promoters, introns, exon/intron boundary regions or synonymous
changes in exons.
Haplotype tests of association
Five genes from maternal data (CRHBP, FV, IL-5, tPA, and
PTGER3) and three in fetal data (CBS, IL-10RA, and TREM1)
that showed highly significant associations with PTB were
analyzed for haplotype association. The full list of all markers
examined for haplotype analyses are available in supplemental
material (Supplemental Tables S2 and S3). Detailed LD structure
for maternal and fetal genes for cases and controls are available in
supplemental material (Supplemental Figure S1, S2, S3, S4, S5,
S6, S7, S8, S9, S10, S11, S12, S13, S14, S15 and S16). Table 7
has the results of the haplotype association analyses with only the
significant haplotypes and their ORs reported.
Among all haplotype sliding window analyses, maternal FV had
the most significant global p value (,1.00610
23) (Table 7;
Supplemental Figure S7 and S8) associating intronic markers
rs12131397-rs9332624-rs9332618 with PTB (cases). The A-A-C
haplotype (rs12131397-rs9332624-rs9332618; OR=1.57 [CI
1.11–2.21], p=8.00610
23) was the only significant haplotype.
Two of these three markers (rs121313197 and rs9332618) are in
strong LD (D’=1) in both cases and controls (Supplemental Figure
S7 and S8). The association does not appear to be main effect
driven as rs9332624 is the only marker with a main effect but its
MAF (0.03 in cases and 0.01 in controls) is low and does not
appear to be contributing greatly to the haplotype association. tPA
(p=6.00610
23) and PTGER3 (p=3.00610
23) both had very
significant global p values for haplotype sliding windows. The
haplotype associations observed in tPA at rs4471024-rs2020922-
rs879293-rs2299609 appear to be main effect driven by rs879293
as the rs879293 G allele was common to both associated
haplotypes (C-A-G-G, OR=1.82 [CI 1.20–2.76],
p=3.00610
23; T-T-G-C, OR=1.62 [CI 1.03–2.55], p=0.03)
and the baseline haplotype included A. Two non-overlapping
haplotypes were associated in PTGER3, rs977214-rs6665776-
rs594454 and rs2050066-6424414-rs2300167 both located in
intronic regions. The pattern of haplotype associations suggests
that both associations are main effect driven; the first haplotype is
driven by the effect of rs594454 and the second haplotype by
rs2300167, which are in strong LD.
Examining the three genes in fetal data (Table 7; Supplemental
Figure S11, S12, S13, S14, S15 and S16), the associated haplotypes
were in CBS (rs1005584-rs6586282 global p=9.00610
23), CBS
(rs1005584-rs6586282-rsrs6586283 global p=9.00610
23), IL-
10RA (rs4938467-rs11216666 global p=0.02), and TREM1
(rs1817537-rs3804277-rs4711668 global p=2.00610
23). In CBS
only the global haplotype association was significant. IL-10RA had
an associated haplotype C-C (rs4938467-rs11216666, OR=2.31
[CI 1.33–4.04], p=1.00610
23), and this haplotype did not appear
to be main effect driven. The TREM1 associated haplotype was for
C-A-C (rs1817537-rs3804277-rs4711668, OR=1.61 [CI 1.04–
2.51], p=0.02). The TREM1, C-A-C (rs1817537-rs3804277-
rs4711668), haplotype association appears to be driven by the
effects of haplotype C-A (rs1817537-rs3804277), as the baseline was
G-G-C and rs4711668 C was common to both the associated
haplotypeand the baseline,suggesting that this markeris not greatly
contributing to the haplotype effect.
Evidence for pathway involvement
In the maternal data the genes in complement and coagulation
pathway had a significant excess of associating SNPs in both the
Table 5. Single locus association genotypic logistic
regression analyses adjusted for smoking and gravidity
Population Gene(s) SNP rs# Adjusted Model P
1
Maternal CRHBP rs1875999 0.02
rs32897 5.00610
23
rs10055255 6.00610
23
FV rs9332624 -
IL-5 rs739718 0.08
tPA rs879293 ,1.00610
23
PTGER3 rs977214 0.14
rs594454 3.00610
23
SCNN1A rs3764874 0.03
Fetal CBS rs12329764 0.27
IL-10RA rs17121510 0.29
KL rs9527025 0.14
rs522796 0.04
TREM1 rs6910730 0.20
1P value for model in Table 5 adjusted smoking and gravidity
doi:10.1371/journal.pone.0003283.t005
Table 6. Single locus association analyses testing for allele
and genotype differences between cases with and without
MIAC
Population Gene(s) SNP rs# PTB MIAC v PTB No MIAC
Allele P Genotype P
Maternal CRHBP rs1875999 0.57 0.39
rs32897 0.54 0.55
rs10055255 0.42 0.73
FV rs9332624 0.33 0.68
IL-5 rs739718 1.00 1.00
tPA rs879293 0.19 0.51
PTGER3 rs977214 0.19 0.47
rs594454 0.74 0.36
SCNN1A rs3764874 0.81 0.95
Fetal CBS rs12329764 0.43 0.76
IL-10RA rs17121510 0.87 0.86
KL rs9527025 1.00 0.20
rs522796 0.17 0.06
TREM1 rs6910730 0.02 0.05
doi:10.1371/journal.pone.0003283.t006
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Several other KEGG defined pathways also had an excess of
maternal associations, but only the cytokine-cytokine receptor
showed an excess of associations with the fetal data.
Multilocus analyses
Multilocus analyses on pathways with an excess of significant
associations for either allele or genotype tests (identified by Z tests
analyses) revealed a statistically significant two locus model in the
complement and coagulation pathway in maternal data after
excluding the single most significant tPA marker (rs879293)
(Figure 1). This model included markers from Factor V and
Factor VII with a balanced testing accuracy of 61.58% and a cross
validation consistency of 10.
Discussion
In the present study a high-throughput candidate gene
association analysis was performed on PTB candidate genes in
an effort to further understand genetic factors associated with PTB
in a US Caucasian sample. Comprehensive single locus and
haplotype analyses were performed and revealed several interest-
ing results in both maternal and fetal data. The most significant
association in maternal data were seen in tPA, a gene involved in
the complement and coagulation pathway, with other associations
observed in genes involved in neuro-signaling and infection/
inflammatory response. Fetal data, in contrast to maternal data,
had neither highly significant associations nor an excess of
significant associations in genes involved in the complement and
coagulation pathways, but did have an excess of significant
associations in infection/inflammatory response PTB pathways.
To further understand the significance of these variants in the
pathophysiology of preterm birth a preliminary analysis was
performed to putatively identify the potentially most important
Table 7. Haplotype frequencies and OR for strongest sliding window
Population Gene(s) Markers Global P
1 Haplotype Frequency OR 95% CI P
Cases Controls
Maternal CRHBP rs32897-rs6453267-rs10055255-rs1875999 0.01 A-G-A-A 0.65 0.53 1.00 - -
A-G-T-G 0.10 0.18 0.45 0.27–0.74 9.00610
24
FV rs12131397-rs9332624-rs9332618 ,1.00610
23 C-A-C 0.43 0.52 1.00 - -
A-A-C 0.44 0.34 1.57 1.11–2.21 8.00610
23
IL5 rs739719-rs739718 0.01 G-A 0.90 0.94 1.00 - -
T-G 0.09 0.03 2.70 1.30–5.85 4.00610
23
tPA rs4471024-rs2020922-rs879293-rs2299609 6.00610
23 T-T-A-C 0.32 0.42 1 - -
C-A-G-G 0.29 0.21 1.82 1.20–2.76 3.00610
23
T-T-G-C 0.21 0.17 1.62 1.03–2.55 0.03
PTGER3 rs977214-rs6665776-rs594454 3.00610
23 A-C-T 0.56 0.47 1.00 - -
A-C-G 0.31 0.44 0.59 0.42–0.83 2.00610
23
rs2050066-rs6424414-rs2300167 3.00610
23 C-C-C 0.31 0.40 1.00 - -
C-T-T 0.30 0.26 1.47 0.98–2.21 0.05
C-C-T 0.29 0.21 1.76 1.15–2.67 6.00610
24
Fetal CBS rs1005584-rs6586282 9.00610
23 -- - - --
rs1005584-rs6586282-rs6586283 9.00610
23 -- - - --
IL10RA rs4938467-rs11216666 0.02 T-T 0.43 0.51 1.00 - -
C-C 0.16 0.08 2.31 1.33–4.04 1.00610
23
TREM1 rs1817537-rs3804277-rs4711668 2.00610
23 G-G-C 0.48 0.48 1.00 - -
C-A-C 0.25 0.16 1.61 1.04–2.51 0.02
1Global P is the p-value for the haplotype sliding window
*Only haplotypes with frequencies of 5% in at least one status group and with a significant OR are presented.
*ORs are calculated comparing each haplotype to the highest frequency haplotype.
doi:10.1371/journal.pone.0003283.t007
Table 8. Significant results by KEGG pathway using only tags
KEGG Pathway (tags with r2$0.60) # Genes Caucasian
Maternal Fetal
Apoptosis 12
Arachidonic acid metabolism 5
Complement and coagulation cascade 6 *{
Cytokine-cytokine receptor interactions 31 * *{
Focal adhesion 6 *
Hematopoietic cell lineage 12 *
Jak-STAT signaling pathway 14
MAPK signaling pathway 18
Neuroactive ligand-receptor interaction 12
T cell receptor signaling pathway 12
Toll-like receptor signaling 14
Type I diabetes mellitus 7
*indicates statistically significant allelic association
{indicates a statistically significant genotypic association
doi:10.1371/journal.pone.0003283.t008
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significant excess of associations for both the allele and genotype
tests in maternal data. The cytokine-cytokine receptor pathway
was significant for both allele and genotype tests for fetal data.
Upon examining the complement and coagulation pathway in
more detail it was found that in the fibrinolytic branch of the
pathway, three of four genes genotyped in that branch had
markers that were significantly associated (Figure 2). These genes
were factor VII (FVII), FV, and tPA. Two other genes upstream
and downstream of this branch did not associate (soluble mannose-
binding lectin (protein C) 2 (MBL2) and factor II [FII]). The only
result to stand up to a Bonferroni correction was tPA, from the
complement and coagulation cascade. A preliminary multi-locus
analysis using multifactor dimensionality reduction (MDR)
analysis revealed an interesting association between FV
(rs2187952) and FVII (rs3211719) within the complement and
coagulation cascade that suggests that there may be both an
interaction among genes within the pathway and heterogeneity
among these genes (Figure 1).
The majority of previous studies on PTB have focused on
pathways contributing towards intrauterine infection [30], ignor-
ing the potential contribution of other pathways such as decidual
hemorrhage. Decidual hemorrhage is found in ,45% of patients
with PTB [31]. Expression studies of decidual tissues have
observed that tissue factors and tPA have strong patterns of
expression [32–34]. To the best of our knowledge no other studies
have associated tPA markers with PTB; however, several studies
have observed increased tPA and tissue factors expression in
preterm compared to term human decidual tissues [34,35]. tPA is
a serine protease inhibitor in the fibrynolitic cascade (Figure 2) that
converts inactive plasminogen to plasmin. The generation of
plasmin is important for the degradation of components of the
extra cellular matrix (ECM) by activating matrix metalloproteases
(MMPs) that breaks down interstitial collagens. Although the
functional relevance of tPA variants are unknown, over expression
of tPA leads to plasmin production, MMP activation and ECM
degradation that is commonly associated with fetal membrane
rupture and cervical ripening associated with PTB. Our
association with tPA seen in maternal samples supports previous
findings observing elevated levels of tPA in maternally derived
decidua, but not in fetally derived amnion/chorion tissues [34,35].
Another strong association was also observed in CRHBP in
maternal DNA. CRHBP plays an important role in binding of
corticotrophin releasing hormone (CRH) of the HPA axis.
Figure 1. MDR complement and coagulation two locus model between FV and FVII. a. Testing accuracy and cross validation consistency
for the best one to three locus models. b. Best multilocus model in the complement and coagulation pathway - Each multifactor cell is labeled as
‘‘high risk’’ or ‘‘low risk’’. For each multifactor combination, hypothetical distributions of cases (left bar in cell) and controls (right bar in cell) are shown.
Each cell represents a multilocus genotype; the genotype is labeled on the figure. The testing average balanced accuracy is 61.58% (p-
value,1.00610
23) with a cross-validation consistency of 10/10. Logistic regression analyses showed that the interaction for the effects of these two
markers was statistically significant (p=0.009) and the likelihood ratio test p value for including the interaction in the logistic regression model was
0.0072.
doi:10.1371/journal.pone.0003283.g001
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PLoS ONE | www.plosone.org 8 September 2008 | Volume 3 | Issue 9 | e3283CHRBP functions by inactivating CRH, preventing inappropriate
pituitary-adrenal stimulation in pregnancy[36]. Of potential
importance are the observations that tPA and the cascade of
CRH have been shown to be functionally related. CRH is released
by several cell types, including but not limited to neuronal cells,
the gastrointestinal tracts, placenta, and fetal membranes; tPA is
released in response to CRH and acts downstream of CRH
receptor 1 (CRHR1), a necessary step for the activation of stress
related response [37], a major etiologic factor associated with
PTB. This relationship is of interest because it implicates tPA in
the maternal-stress PTB pathways in addition to decidual
hemorrhage pathways. If CRHBP does not function appropriately
it may prevent the inactivation of CRH, causing the release of tPA
and the activation of stress related response. However, despite the
biological relationship between these two genes, no statistical
associations were observed between them.
Single locus tests of association in fetal data were not as strong
as maternal data and were not statistically significant after
adjusting for the effects of confounders (gravidity and smoking)
with the exception of KL (rs522796). PTB with and without
MIAC did not differ with the exception of TREM1 marker
rs6910730. The cytokine-cytokine receptor interaction pathway,
was the only pathway showing an excess of significant findings in
fetal data. The cytokine-cytokine receptor interaction pathway was
also observed in maternal data, which may be the result of either
maternal-fetal allele sharing or of independent associations in
mother and baby; however, such relationships can only be clarified
by assessment of paternal contribution by the use of a family-based
study design. Although we did not have the power to detect very
small effect sizes, especially after an adjustment for multiple
testing, we did have the power to find associations with large effect
sizes, as we did with tPA. This may be a limitation to our study.
However, by finding several effects in the same pathways, using
even an alpha level of 0.05 for significance, we were able to
identify those pathways of the greatest importance in our data set,
and reinforced the overall findings. This allowed us to look for
patterns of associations, considering both large and small effects.
In conclusion, we conducted a gene-centric association study on
PTB and found several interesting associations confirming several
established PTB candidates. Despite basing our candidates on
preterm birth pathways [18], we analyzed genes according KEGG
biological pathway and found several interesting associations,
including a result that stood up to a Bonferroni correction. Sample
size is a major limitation to our study; however, our samples were
well phenotyped and phenotypically quite homogenous. Given the
patterns of associations observed within genes and by pathway, it is
clear that several of the findings are consistent with the established
literature. We replicated association with FV, a well established
PTB candidate also found using a large-scale high throughput
genotyping platform and identified new candidates [38]. This
association was previously observed in a black population;
however, our study suggests that it was not necessarily population
specific given that we found the association in Caucasians. We
stress that although our results are very promising independent
replication is necessary in order to validate these associations. Our
strongest association was in the decidual hemorrhage pathway,
indicating that this pathway may be very important for the
initiation of PTB and should be focused on in future studies.
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